The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function by Guillon, Noëlle et al.
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA
Microsatellite Sequences with Potential Transcriptional
Activation Function
Noe ¨lle Guillon
1,2., Franck Tirode
1,2., Valentina Boeva
1,2,3, Andrei Zynovyev
1,3, Emmanuel Barillot
1,3,
Olivier Delattre
1,2*
1Institut Curie, Paris, France, 2INSERM, U830, Ge ´ne ´tique et Biologie des Cancers, Paris, France, 3INSERM, U900, Cancer et Ge ´nome: bioinformatique, biostatistiques et
e ´pide ´miologie d’un syste `me complexe, Paris, France
Abstract
The fusion between EWS and ETS family members is a key oncogenic event in Ewing tumors and important EWS-FLI1 target
genes have been identified. However, until now, the search for EWS-FLI1 targets has been limited to promoter regions and
no genome-wide comprehensive analysis of in vivo EWS-FLI1 binding sites has been undertaken. Using a ChIP-Seq approach
to investigate EWS-FLI1-bound DNA sequences in two Ewing cell lines, we show that this chimeric transcription factor
preferentially binds two types of sequences including consensus ETS motifs and microsatellite sequences. Most bound sites
are found outside promoter regions. Microsatellites containing more than 9 GGAA repeats are very significantly enriched in
EWS-FLI1 immunoprecipitates. Moreover, in reporter gene experiments, the transcription activation is highly dependent
upon the number of repeats that are included in the construct. Importantly, in vivo EWS-FLI1-bound microsatellites are
significantly associated with EWS-FLI1-driven gene activation. Put together, these results point out the likely contribution of
microsatellite elements to long-distance transcription regulation and to oncogenesis.
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Introduction
Ewing tumors, the second most frequent bone tumors in
teenagers and young adults, show specific translocations fusing the
59 part of EWS to the 39 sequence encoding the DNA binding
domain of an ETS factor [1,2]. In most cases, translocations occur
between chromosomes 11 and 22, leading to the formation of the
aberrant EWS-FLI1 chimeric transcription factor [3]. In rarer
cases, ERG, E1AF, ETV1 or FEV that encode other ETS family
members are fused to EWS [4–7]. Various experimental
procedures, including SELEX experiments and mapping of
promoters regulated by EWS-FLI1, have shown that ETS factors
bind purine-rich sequences with a GGAA/T core consensus
sequence, surrounded by nucleotides that contribute to the
specificity of each factor [8–11]. This was recently highlighted
by a large-scale study of the properties of ETS factors promoter
occupancy showing that DNA binding may be divided into two
complementary mechanisms [12]. The first would imply a core
ETS consensus site that may be recognized by a large proportion
of ETS factors, with the consequence of binding of various ETS
proteins to common genomic targets. The second process would
involve more specific mechanisms, with the recognition of less
typical binding sites, possibly in cooperation with other DNA-
binding factors.
EWS-FLI1 can recognize in vitro the same sequences as FLI-1
[8], but is a more potent transactivator than the wild type factor
[13,14]. It is now largely agreed that EWS-FLI1 oncogenic
potential is at least partially mediated by the expression
modulation of transcriptional targets. Numerous genes whose
expression is modulated by EWS-FLI1 have been described. They
exhibit very diverse functions including cell cycle regulation, cell
migration, morphogenesis or signal transduction (reviewed in [2]).
So far, only few genes have been unambiguously validated as
direct EWS-FLI1 targets in the context of Ewing cells. These
includes TGFbRII [15], cyclinD1 [16], Id2 and c-Myc [17],
IGFBP3 [18], PTPL1 [19], cyclinE [20], MK-STYX [21],
caveolin1 [22] and Dax1/NR0B1 [23,24]. In most cases, one or
several ETS consensus sites could be detected in the promoter or
first intron of these genes and shown to be crucial for EWS-FLI1
binding and transcription modulation [19,25–28]. EWS-FLI1 may
also be associated with other cofactors on particular modular
response elements, such as on the Serum Response Element in
cooperation with SRF [29,30], or on composite ETS-AP-1 tandem
elements [31].
Recently, two reports indicated that the binding of EWS-FLI1
may not be limited to bona fide ETS binding sites but may also
occur on GGAA repeats. Indeed EWS-FLI1 regulates the NR0B1
promoter through direct binding to a GGAA microsatellite
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between the number of GGAA modules and the level of NR0B1
expression raising the hypothesis that several EWS-FLI1 mono-
mers may cooperate on a GGAA-rich region [32]. Gangwal et al.
conducted a ChIP-chip promoter wide analysis of EWS-FLI1
binding sites and reported that the regulation of other EWS-FLI1
targets may also rely on such microsatellite sequences. So far, the
search for EWS-FLI1 targets has been restricted to promoter
regions and the precise in vivo significance of GGAA microsatellites
with respect to expression modulation remains elusive.
In an attempt to decipher a general EWS-FLI1 DNA binding
mechanism and to identify candidate direct target genes in the
Ewing tumor context, we have combined high throughput
sequencing of EWS-FLI1 bound DNA fragments and analysis of
EWS-FLI1-induced gene expression modulation. Our approach
demonstrates binding of EWS-FLI1 to GGAA-repeat sequences in
vivo and further shows a binding preference for tracts of 9 repeats
or more. We also extend the repertoire of EWS-FLI1 bound
GGAA microsatellites and show that, although these sites may be
distant from transcription start sites, they are significantly enriched
in regions encoding EWS-FLI1 regulated genes. Such results point
out the large contribution of GGAA-microsatellite elements to
EWS-FLI1 regulation of targets.
Materials and Methods
Chromatin immunoprecipitation
Cross-linking was performed with 10
6 A673, SK-N-MC or
MON cells in medium with 1% of formaldehyde for 8 min. Cells
were then lysed in 200 mL SDS lysis buffer (1% SDS; 10 mM
EDTA; 50 mM Tris, pH 8.1) and sonicated for 10 min at power 3
(20% duty cycles) using ultrasonic processor GE375 apparatus
(Meditech Scientific, Clamart, France). Cell lysates were diluted 10
fold in ChIP dilution buffer (0.01% SDS; 1.1% Triton X-100;
1.2 mM EDTA; 16.7 mM Tris, pH 8.1; 167 mM NaCl),
precleared for 15 min with protein A-Sepharose and incubated
overnight at 4uC with 10 mg anti-FLI-1 C19 antibody (Santa
Cruz, CA.). Protein A-Sepharose was then added for 15 min at
4uC. After sequential washes (16 Low Salt Wash Buffer: 0.1%
SDS; 1% Triton X-100; 2 mM EDTA; 20 mM Tris-HCl, pH 8.1;
150 mM NaCl; 26High Salt Wash Buffer: 0.1% SDS; 1% Triton
X-100; 2 mM EDTA; 20 mM Tris-HCl, pH 8.1; 500 mM NaCl;
16LiCl Wash Buffer: 0.25 M LiCl; 1% Igepal; 1% deoxycholic
Acid; 1 mM EDTA; 10 mM Tris-HCl pH 8.1; 26 TE Wash
Buffer: 10 mM Tris pH 8.1; 1 mM EDTA) and elution from the
beads with 1% SDS, cross-links were reversed for 4 h at 65uC.
Proteins were then digested by adding 100 mg/mL Glycogen and
200 mg/mL of Proteinase K (Invitrogen, CA) for 1 h at 45uC and
DNA, which was recovered by phenol/chloroform extraction, was
ethanol precipitated and resuspended in 15 mL of water. DNA was
quantified using Quant-iT technology and the Qubit quantifica-
tion platform from Invitrogen.
Illumina library construction and sequencing
Immunoprecipitated DNAs were processed and analysed on the
Illumina/Solexa platform by the Fasteris company (Geneva,
Switzerland). Briefly, DNA ends were repaired using a 1:5 mixture
of T4 and Klenow DNA polymerases following the manufacturer’s
instructions. After addition of a single adenine base to the DNA
using Klenow exo-, adapters were ligated to the ends of the single
adenine-tailed purified DNA. Adapter-modified DNA fragments
were enriched by PCR using the Phusion polymerase (Finnzymes,
Finland) and PCR primer 1.1 and 2.1 (Illumina) following the
manufacturer’s instructions. DNA was then size-selected at around
300 bp on a 12% PAGE gel. Cluster generation on one channel of
the Illumina cell for each sample and 27 cycles of sequencing were
performed on the Illumina cluster station and 1G analyzer.
Processing 1G data
Reads were mapped to the unmasked human reference genome
(NCBIv36, hg18) using the Eland alignment tool (Illumina), with a
tolerance of up to two mismatches per read sequence. Then,
uniquely mapped sequence reads were processed by FindPeaks
3.1.9.2 software [34] in order to detect enriched regions. The
threshold of 7 on the minimum peak size was adopted to identify
read clusters in EWS-FLI1 cell lines, whereas read clusters in the
MON control were selected with a lower threshold of 4. By
filtering out clusters common to the Ewing and MON control cell
lines, we defined EWS-FLI1 specific areas of enrichment. Since
pericentromeric regions are often a source of noise in ChIP-Seq
data [35], the corresponding read clusters were removed from
subsequent analysis. For enrichment analyses, 50 000 non-
overlapping random regions, exclusive of pericentromeric regions,
were used as control. These regions were selected to have the same
size distribution than the EWS-FLI1-bound regions identified by
FindPeaks
DNA Motif Analyses
ETS binding site analyses were performed using the Region-
Miner tool (Genomatix, Germany) with position weight matrices
for families of transcription factors or for individual factors.
MEME program, version 3.5.1 was used to search for DNA
motifs. To generate logos from the MEME output, the WebLogo
software program, version 2.8.2 (http://weblogo.berkeley.edu/),
was used.
GGAA microsatellites sequencing
Pairs of primers were designed for each GGAA microsatellite
genomic region (listed in Supporting Table S3). After fragment
amplification using Phusion polymerase (Finnzymes), DNA was
purified with the Nucleofast system (Macherey-Nagel, Hoerdt,
France) and sequenced using Big Dye V1.1 (Applied Biosystems,
Courtaboeuf, France).
Luciferase assays
Varying numbers of GGAA motifs were cloned in the pGL3-
promoter vector (Promega, Charbonnieres, France). EWS-FLI1
cDNA was cloned in the pCDH1-MCS1-puro vector (System
Biosciences, CA). 293T and shA673-1C cells were transfected with
firefly reporters, the renilla encoding plasmid (pREP7-Rluc, kindly
provided by Keji Zhao) and pCDH1-EWS-FLI1 or control
plasmids. Firefly activity was normalized to Renilla luciferase
activity to adjust differences in transfection efficiency.
Results
EWS-FLI1 binds in vivo to GGAA microsatellites and
GGAA-rich sequences
We used chromatin-immunoprecipitation coupled to high
throughput sequencing (ChIP-Seq) to construct a high-resolution
EWS-FLI1-binding map. Immunoprecipitation experiments were
conducted in SK-N-MC and A673, two Ewing cell lines that
express type 1 EWS-FLI1, and in MON, a malignant rhabdoid
tumor (MRT) cell line. The antibody that was used is directed
against the C-terminus part of FLI1. It could theoretically
immunoprecipitate wild type FLI1, however this protein is
expressed in none of the three afore-mentionned cell lines. We
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share common characteristics: they both belong to the group of
small round cell tumors of children and may share a mesenchymal
stem cell of origin [36,37]. However, MRTs do not harbor the
EWS-FLI1 rearrangement.
For each sample, between 1.9 and 3.5 million sequences with a
mean length of 35 nt were obtained. Of these, approximately 80%
had a single location on the human genome (Table 1). Analysis of
these sequences was carried out with the FindPeaks program [34].
This identified 26, 94 and 195 EWS-FLI1 specific read clusters in
the SK-N-MC and in each of the two A673 cell line samples,
respectively. Read clusters were selected as EWS-FLI1 specific if
no cluster was found at the same position in the MON control. A
total of 246 regions was thus identified as EWS-FLI1 specific
(Table S1), 14 being specific to SK-N-MC cell line, 220 to A673
and 12 common to both cell lines. The size of identified regions
varied from 329 to 2247 bp with an average length of 725 bp.
In order to characterize EWS-FLI1 consensus binding sites, over-
representation of sequence motifs was searched for. Frequencies of
every possible 4–8 bp long oligomer were assessed in the 246 EWS-
FLI1specificregions compared to their respective frequencies inthe
human genome. A clear over-representation of oligomers contain-
ing GGAA motifs was observed (results obtained for 6-mer motifs
are displayed in Fig. 1A). More precisely, 104 regions presented
microsatellite sequences consisting of 3 or more GGAA-containing
tandem repeats: (GGAA)n, (GGAAN)n or (GGAANN)n. The other
142 regions did not contain such microsatellites. Both types of
regions were found in A673 and SK-N-MC cell lines (Fig. 1B),
indicating that neither type of region was cell specific. The
RegionMiner and MatInspector softwares (Genomatix) were used
to assess whether the two types of EWS-FLI1 specific regions were
enriched in bona fide ETS factor binding sites. Regions containing
microsatellites did not show any additional ETS consensus over-
representation after repeat filtration (Table S2). In contrast, a clear
over-representation of ETS family binding motifs was observed in
the EWS-FLI1-specific regions that do not contain microsatellite
sequences (Table 2). These regions also presented very frequent
combination of two ETS sites or of ETS site with consensus sites for
other transcription factors (Table 3). These non-microsatellite
EWS-FLI1 specific regions were also analyzed with the MEME
software that defines position weight matrices giving frequency
distributions of each base at each position [38]. As shown in
Figure 1C, MEME retrieved a consensus sequence highly similar to
an ETS binding sequence.
These observations suggested at GGAA microsatellites and bona
fide ETS containing regions constitute two types of EWS-FLI1
binding regions in Ewing cells.
EWS-FLI1 preferentially binds microsatellites with more
than 9 GGAA repeats
In order to analyze whether EWS-FLI1-binding was skewed
toward particular numbers of GGAA repeats we compared the
number of GGAA repeats between EWS-FLI1-bound and
random regions. The mean number of GGAA amongst the 246
EWS-FLI1-bound regions over the mean number of GGAA
amongst random regions was dramatically increased. This was
particularly obvious for a number of GGAA higher than 9
(Fig. 2A). In order to evaluate the size of the microsatellites in
Ewing cells, the sequence of 51 EWS-FLI1-bound microsatellites
was determined in the A673 and SK-N-MC cell lines. This
showed that most microsatellites were polymorphic. However, the
range of GGAA repeats number was consistent with that reported
in public database (Table S1). Altogether, these data suggest that
EWS-FLI1 may preferentially bind in vivo microsatellites with more
than 9 repeats (hereafter called microsatellites.9R).
To test the responsiveness of such microsatellites structures to
EWS-FLI1, luciferase assays were performed using different
numbers of GGAA repeats cloned into the pGL3-promoter
reporter vector (Fig. 2B). Experiments were performed in a Ewing
cell line that contains a doxycyclin-regulated EWS-FLI1 specific
shRNA, shA673-1C [37], and in 293T cells transfected with an
EWS-FLI1-expression vector. In both cases, in the presence of
EWS-FLI1, very strong luciferase activities could be detected with
the constructs containing at least 10 GGAA repeats while mild
luciferase activities were detected when the constructs contained a
lower number of repeats. These luciferase activities were
dependent on EWS-FLI1 since doxycyclin inhibition of EWS-
FLI1 expression in shA673-1C (+Dox) or transfection of 293T
with empty vector (293T CTL) led to little or no activation of the
reporter gene (Fig. 2B).
Enrichment for EWS-FLI1 regulated genes around
binding sites
Among the 246 EWS-FLI1 specific regions, 146 were localized
in intergenic regions, 13 in exons, 79 in gene introns and 8 in
promoters. These EWS-FLI1 binding sites were very frequently
located far away from any transcription unit, with a mean distance
to transcription start sites of 242 Kb and up to 3 Mb. To address
the issue of a potential link between EWS-FLI1 bound regions and
EWS-FLI1 regulated transcription, we compared the distances of
the 246 EWS-FLI1-specific regions or of randomly picked regions
to the nearest EWS-FLI1 regulated gene. We used a previously
published list of EWS- FLI1 regulated genes that were identified
through shRNA inhibition experiments in A673 and SK-N-MC
Ewing cell lines [37]. This list contains 557 and 577 genes that are
down- or up-regulated by EWS-FLI1, respectively (fold
change.|2| with a Welsh p-value,0.01). Figure 3A shows the
percentage of EWS-FLI1-bound or random regions with an EWS-
FLI1-modulated gene at a given distance. It is interesting to note
that about 43% of the 246 EWS-FLI1 bound regions have the
transcription start site of an EWS-FLI1-up-regulated gene within
1 Mb (as compared to 27% for random regions) and 60% within
2 Mb (46% for random). The increased proportion of EWS-FLI1-
down-regulated genes located within 1 or 2 Mb of EWS-FLI1
regions is less obvious (31% as compared to 24% for random
regions and 47% as compared to 42%, respectively). These results
indicated that the 246 EWS-FLI1 bound regions were significantly
closer to EWS-FLI1-regulated genes than randomly selected
regions (Mann-Whitney p-value,10
216). However, no correlation
between expression level of genes and their distance to
microsatellites.9R could be found. To further analyze the link
between EWS-FLI1 transcriptional expression modulation and
EWS-FLI1-bound microsatellites, GSEA analyses were performed
[39]. As expression dataset, we used the afore-mentioned
published data [37,40], ranked using the signal-to-noise metric.
The gene set contained the genes flanking the 80 regions
Table 1. Number of reads and corresponding mapped
sequences per Chip-Seq experiments.
Reads SK-N-MC A673 (1) A673 (2)
MON
(control)
Total sequenced 2,961,880 1,888,878 3,466,371 2,473,927
Total uniquely mapped 2,577,613 1,656,023 3,004,601 1,982,019
doi:10.1371/journal.pone.0004932.t001
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of Figure 3B, the gene set is overrepresented at the left edge that
contains EWS-FLI1 up-regulated genes. Indeed, among the 94
genes flanking the microsatellites.9R, 30 were at the leading edge
(Z-score=8.6, Fisher p-value=2.1610
211). GSEA analysis car-
ried on the regions bound by EWS-FLI1 that do not contain
GGAA microsatellite is shown on Figure 3B, lower panel. This
shows that relative enrichments are observed at both edges,
however the GSEA overall statistics do not reach significance. This
analysis demonstrated that EWS-FLI1 up-regulated genes are
significantly enriched in the vicinity of EWS-FLI1-bound
microsatellites with more than 9 GGAA repeats therefore
suggesting that microsatellites.9R are associated with a function
of EWS-FLI1 in transcription activation.
Reciprocally, we investigated whether upstream regions of
EWS-FLI1 modulated genes were enriched with microsatelli-
tes.9R. The 1 Kb cumulative frequency of GGAA repeats was
calculated from the transcription start site to 1 Mb upstream of
EWS-FLI1-regulated genes [37], as well as of a set of 561 control
genes that were found expressed but not modulated in the same
experiments (Fold Change,|1.1| with a log2 expression value
between 4 and 7). These frequencies were then compared to the
frequency of GGAA repeats found up to 1 Mb upstream of the
start sites of 17000 known genes (Fig. 3C). The number of GGAA
microsatellites.9R located upstream of EWS-FLI1-up-regulated
genes was clearly higher than for other known genes (Fig. 3D,
Mann-Whitney test p-value,10
212). This overrepresentation was
observed neither for small (3 to 9 repeats) microsatellites nor in the
upstream regions of EWS-FLI1-down-regulated genes (Fig. 3E)
nor for genes that are expressed in Ewing cells but not modulated
by EWS-FLI1 (Fig. 3F). Moreover, the same enriched distribution
was not observed for GGAT repetitions (data not shown). This in
silico analysis shows that upstream regions of EWS-FLI1 up-
regulated genes are enriched for GGAA microsatellites.
Overall, these observations strongly suggest that a large part of
EWS-FLI1 DNA binding is driven by GGAA sequence recogni-
tion and correlates with genes expression activation through EWS-
FLI1 driven long-distance control of transcription.
Discussion
EWS-FLI1 driven oncogenesis is thought to rely mainly on
DNA binding and subsequent alteration of the expression of
specific target genes. Up to now, studies aiming at finding EWS-
FLI1 target genes investigated exclusively binding to promoter
regions either through genome wide approaches or through
specific analyses of genes transcriptionally modulated by this
oncogene. In order to identify EWS-FLI1 specific in vivo target
genes in an unbiased genome wide approach, we used here
chromatin immunoprecipitation coupled with high throughput
sequencing.
Our findings uncover two types of EWS-FLI1 binding
sequences: (i) consensus ETS binding sites and (ii) GGAA
Figure 1. EWS-FLI1 binds GGAA microsatellites or GGAA-rich sequences. A. Enrichment of GGAA motifs in EWS-FLI1-bound sequences.
Frequencies of each of 4096 possible 6mer nucleotides found for the 246 identified EWS-FLI1 specific regions (black circle) and for regions identified
in the control experiment (white circle) are represented along the Y axis whereas frequency of the same 6mers in the genome is represented on the X
axis. B. GGAA repeat enrichment is a common feature of Ewing cell lines. Number of sequences found in A673 (grey circle) and SK-N-MC (white circle)
for each type of binding site. C. Consensus motif assessed with MEME algorithm (E-value=4.1610
246) in regions other than GGAA microsatellites.
doi:10.1371/journal.pone.0004932.g001
Table 2. Transcription factor consensus sites enrichment in
regions other than GGAA microsatellites.
TF Matrices
Over representation
(1) Z-Score (1)
Number of
Matches
V$ELK1.02 10.4 41.82 207
V$CETS1P54.01 6.83 35.63 256
V$ETS1.01 5.76 29.28 219
V$ETS2.01 4.14 26.97 306
V$ELK1.01 5.62 26.63 188
V$FLI.01 5.86 26.39 174
V$ELF2.01 4.31 24.5 237
(1) Compared to the genomic representation.
doi:10.1371/journal.pone.0004932.t002
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expected for the EWS-FLI1 factor, considering its common
binding properties with wild type FLI1. Our approach not only
broadens the list of such sites as EWS-FLI1 direct targets, but also
points out their significant association in pairs or with other
transcription factors binding sites within modules. The association
of ETS binding sites with binding sites for factors such as CREB or
NFkB may suggest a cooperative interplay of EWS-FLI1 with
other cancer-related factors. The present identification of GGAA
microsatellites as EWS-FLI1 targets confirms and extends a
previous ChIP-on-chip-based, genome-wide analysis of EWS-FLI1
binding sites in promoter regions. Indeed, GGAA microsatellites
were recently described as EWS-FLI1 binding sites within different
promoters, including NROB1, FCGRT and caveolin 1. More-
over, EWS-FLI1 direct interaction with these repeated elements
was validated by gel shift assays [33].
The aforementioned publication describing microsatellites as
EWS-FLI1 targets pointed out a requirement for minimal length
of four GGAA repeats for binding. Our study further indicates
that a strong in vivo overrepresentation is observed for microsat-
ellites containing between 9 and 17 repeats. In agreement with the
hypothesis that such repeats play a role in EWS-FLI1-driven
transcription regulation, we observe that a dramatic effect on
expression of a reporter gene is indeed observed for this range of
repeats both in heterologous 293T and Ewing cells. This is also in
agreement with a recent study on NR0B1 showing that the level of
expression of this gene in different Ewing cell lines is correlated to
the number of GGAA repeats in its promoter [32]. Yet, the precise
mechanism underlying such binding needs further investigation.
Cooperative binding or increased probability of binding due do
the high local concentration of binding sites have been proposed
[32,33]. The DNA conformation, and in particular the DNA
bending that has been previously shown to be crucial for ETS
factors’ binding, may also be influenced by the number of GGAA
repeats [41–43]. Further ChIP-Seq experiments are required to
increase the depth of the analysis and evaluate in vivo the potential
of EWS-FLI1 to bind different microsatellite sequences. In
particular, this will enable to search for the presence in the
vicinity of GGAA repeats of binding sites for specific transcription
factors that may cooperate with EWS-FLI1 for binding. It will also
be very informative to combine these EWS-FLI1 analyses with
genome-wide studies of epigenetic landmarks since chromatin
conformation may be crucial for EWS-FLI1 binding.
Combining the ChIP strategy to global gene expression
microarrays reveals that sites with long GGAA microsatellites
are preferentially localized near EWS-FLI1 positively modulated
genes. Several EWS-FLI1 modulated genes located in the vicinity
of GGAA repeats can now be tested for their implication in Ewing
sarcoma oncogenesis, such as the kinases DLG2 and VRK1, the
latter being involved in cell cycle regulation possibly through the
regulation of p53 function [44,45]. Interestingly, EWS-FLI1 gene
modulation via microsatellites targeting might be more general
than suggested by the present analysis as a number of EWS-FLI1
up-regulated genes that present long GGAA microsatellite
sequences within 1 Mb of their transcription start sites are not
Table 3. Transcription factor modules containing an ETSF
binding site in regions other than GGAA microsatellites.
Modules with
V$ETSF
Over
representation (1)
Z-Score
(1)
Number of
Matches
V$ETSF-V$ETSF 5.43 41.08 468
V$ETSF-V$GREF 5.22 30.55 275
V$ETSF-V$HOXF 2.18 17.92 504
V$CREB-V$ETSF 2.74 16.68 254
V$ETSF-V$NKXH 2.18 14.67 338
V$ETSF-V$NFKB 3.5 14.26 115
V$AP4R-V$ETSF 4.98 13.32 57
V$ETSF-V$NOLF 4.13 13.03 73
V$E2FF-V$ETSF 2.94 12.54 124
V$ETSF-V$OCT1 2.09 12.5 277
V$ETSF-V$ZBPF 2.78 12.48 138
V$ETSF-V$PAX1 6.85 12.42 32
V$ETSF-V$HAND 2.5 12.17 166
V$ETSF-V$NR2F 2.23 11.79 206
V$ETSF-V$MOKF 3.22 11.72 91
V$ETSF-V$SORY 1.95 11.08 265
V$ETSF-V$PARF 2.05 10.98 227
V$ETSF-V$HEAT 2.37 10.81 149
V$ETSF-V$MEF3 6.01 10.78 29
V$ETSF-V$PTF1 4.02 10.17 47
V$BTBF-V$ETSF 4.52 10.03 38
(1) Compared to the genomic representation.
doi:10.1371/journal.pone.0004932.t003
Figure 2. EWS-FLI1 microsatellite length preferences. A. Ratio of the number of GGAA repeats in EWS-FLI1-bound regions to the number of
repeat in 50000 randomly picked regions. B. Ability of EWS-FLI1 to modulate transcription of a reporter gene depending upon the number of GGAA
repeats. Firefly relative to Renilla luciferase activity is shown. Control experiments with the empty pGL3-promoter vector were set to 1.
doi:10.1371/journal.pone.0004932.g002
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promoter locus is not retrieved with the criteria that were used.
However, it is noteworthy that two independent reads were found
at the expected location in the A673 cell line. Nevertheless, other
genes, like TGFBR2, known to be targeted by EWS-FLI1 were
not recovered in our experiments. Moreover, we observed a
relatively poor overlap of the sites found in the two Ewing cell
lines. Taken together, these observations indicate that a total of 3
million reads per sample is obviously not sufficient for a saturating
genomic coverage. More reads are certainly required for an in
depth study of transcription factors such as EWS-FLI1.
Amongst the 80 microsatellites.9R bound by EWS-FLI1 only
5 were found within the first 10 kb upstream of genes (see Table
S1) amid which 4 were found to be regulated by EWS-FLI1 in our
experiments (CAV1, FCGRT, FVT1/KDSR and ABHD6). To
address more globally the question of the putative correlation
between position and expression level, we studied the mean
distances of GGAA microsatellites.9R to genes located at the
leading edge in the GSEA analysis as compared to the other genes
in the same geneset. Although, we observe a trend toward a
shorter distance (267276 bp+/2356993 bp versus 494046 bp+/
2675168 bp) it does not reach significance (welsh p-value=0.09).
Therefore, the bias that we observe for short distances is less
obvious that the one described in a recent report [33]. Indeed, we
observed a significant enrichment of microsatellites.9R in the first
5 kb upstream of up-regulated genes but they only accounted for
1.5% of the microsatellites.9R found within 1 Mb upstream of
up-regulated genes. This relative discrepancy between both studies
Figure 3. Long distance EWS-FLI1 binding on GGAA microsatellites results in significant gene expression activation. A. Proportion of
EWS-FLI1-bound regions, as compared to the proportion of random regions, around EWS-FLI1 regulated genes. The proportion of EWS-FLI1-bound
regions as a function of the distance to the transcription start sites of EWS-FLI1-up or -down regulated genes (solid lines) is shown. As a control, a
similar function is indicated for 1500 randomly chosen regions (dashed line). B. Gene Set Enrichment Analysis (GSEA) of genes flanking EWS-FLI1-
bound microsatellites. The 94 genes flanking the 80 microsatellites.9R regions (upper panel) as well as the 144 genes flanking the non-
microsatellites regions (lower panel) were used as gene set. The expression dataset resulted from previously described EWS-FLI1 inhibition
experiments of A673 and SK-N-MC Ewing cell lines [37,40], ranked using the signal-to-noise algorithm. A strong enrichment of genes flanking EWS-
FLI1 bound GGAA microsatellites among EWS-FLI1 up-regulated genes is observed (upper panel). C–F. Regions upstream of EWS-FLI1 up-regulated
genes are enriched in GGAA-microsatellites. The number of microsatellites with either 3 to 9 GGAA repeats (grey line) or more than 9 repeats (black
line) was calculated for each 1 Kb window from 1 Kb to 1 Mb upstream of the transcription start sites. The numbers of GGAA repeats along DNA are
shown for (C) 17000 known genes (control distribution), (D) 582 EWS-FLI1-up-regulated genes, (E) 558 EWS-FLI1-down-regulated genes and (F) 561
genes that are expressed in A673 and SK-N-MC cell lines but not regulated by EWS-FLI1. The control distribution shown in C is also indicated on part
D, E and F.
doi:10.1371/journal.pone.0004932.g003
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were applied. Gangwal et al. performed a statistical analysis at each
individual ranked position whereas we estimated the significance
of the overall distribution of the GGAA microsatellites with respect
to the distance to start sites of EWS-FLI1 regulated genes. In such
an analysis, even when the GGAA microsatellites located at less
than 5 kb are removed, the analysis remains highly significant
indicating that the effects of GGAA microsatellites may not be
limited to the first 5 kb upstream of the genes. An important
finding of this work is thus that most EWS-FLI1 binding sites
appear to be localized quite far from gene transcription start sites.
This indicates that EWS-FLI1 does not bind and act exclusively
through promoter regions but can also impact transcription at long
distance. Such long distance expression control has been described
for several transcription factors in locus control regions, epito-
mized by the b-globin locus (for review, see [46]). Moreover,
computational prediction of transcriptional regulatory modules
also revealed putative position of transcription factor binding sites
far away from coding sequences [47] and gene deserts are now
scanned in search for enhancer modules [48]. In addition, very
distant genomic region looping has been demonstrated to promote
transcription in transcriptional hubs (reviewed in [49,50]). Future
analyses by chromosome conformation capture of long range
interactions between EWS-FLI1 binding sites, and in particular
GGAA repeats, with other loci are required to study the nuclear
architecture of EWS-FLI1 bound domains.
Finally, it is noteworthy that microsatellite sequences have
previously been associated with genes regulation. Indeed, long
tandem repeats of CCGCC sequence in the promoter of the
SMYD3 histone methyltransferase have been linked to an
increased binding and transactivation by E2F-1 [51]. Moreover,
in this last study, the allele corresponding to the longest CCGCC
repeat was shown to be more represented in individuals with
colorectal cancer, hepatocellular cancer or breast cancer, thus
suggesting a possible role in cancer susceptibility. Polymorphisms
in GGAA repeat numbers of key EWS-FLI1 targets may similarly
constitute attractive candidates to account for Ewing sarcoma
susceptibility [52].
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